HSPG2 and cancer: The parallel decrease in PC-PLC protein content in the investigated D609-treated SKOV3.ip cells was not a general effect of this inhibitor in cancer cells, since no similar changes were found in the mean PC-PLC protein level in the HER2-overexpressing SKBr3 cells exposed to D609.